AI assistant
Humana — Interim / Quarterly Report 2021
May 6, 2021
3059_10-q_2021-05-06_c13fa6b1-30b7-4d43-ba9f-8bb16f5c5f9c.pdf
Interim / Quarterly Report
Open in viewerOpens in your device viewer
Interim report January-March, Q1 2021
Continued good progress in first quarter
First quarter, January–March 2021
- Operating revenue was SEK 1,986m (1,938), an increase of 2%. Organic growth was 2.4%.
- Operating profit was SEK 112m (98), an increase of 14%.
- Net profit after tax for the period amounted to SEK 63m (53).
- Basic and diluted earnings per share for the period amounted to SEK 1.27 (1.00).
- Operating cash flow amounted to SEK 197m (95).
Significant events in and after the end of the quarter
- In February, Humana acquired the Swedish individual and family company Team J-son. Team J-son's annual revenue is approximately SEK 90m and the company has about 120 employees.
- In February and March 2021, Humana repurchased 2,357,348 shares at a cost of SEK 159m, corresponding to an average price of SEK 67.51 per share. Subsequently, the company's total own shareholding amounts to 5,017,059 shares, which is 9.44 percent of the total number of outstanding shares and votes.
- Humana's Board proposes to the 2021 AGM, to be held on 11 May, that no dividend be paid for the 2020 financial year.
Key ratios
| SEK millions | Jan–Mar 2021 |
Jan–Mar 2020 |
% | Apr–Mar 2020/21 |
Jan–Dec 2020 |
% |
|---|---|---|---|---|---|---|
| Net revenue | 1,984 | 1,932 | 3% | 7,822 | 7,771 | 1% |
| Other operating revenue |
2 | 6 | -64% | 22 | 26 | -14% |
| Operating revenue | 1,986 | 1,938 | 2% | 7,845 | 7,797 | 1% |
| Operating profit | 112 | 98 | 14% | 485 | 471 | 3% |
| Adjusted operating profit |
112 | 98 | 14% | 467 | 453 | 3% |
| Net profit for the period | 63 | 53 | 18% | 271 | 262 | 4% |
| Operating cash flow | 197 | 95 | 107% | 881 | 779 | 31% |
CEO Comment
We see a clear and positive effect from the vaccinations. At the same time, vaccination is not a magic bullet, so the systematic preventive efforts linked to the pandemic must continue.
The first quarter of the year was a stable one. The vaccination of our personnel and customers has improved our operational situation and the Humana Group continued to grow organically. Profitability was good with increased operating profit in four out of five business areas and our cash flow was strong.
Revenue amounted to SEK 1,986m in the first quarter and organic growth was 2.4 percent. The Individual & Family, Personal Assistance and Norway business areas were drivers behind this growth. At the same time, the pandemic had a negative impact on revenue due to lower occupancy in elderly care in Sweden and Finland and outpatient care in Finland. Operating profit amounted to SEK 112m, an increase of 14 percent compared with the same quarter last year thanks to higher profit in all business areas except Finland, which faced several parallel challenges. Operating profit together with a decrease in working capital helped to strengthen cash flow in the quarter, which in turn provided scope to repurchase additional shares. Even after these transactions, Group debt was in line with our target at the end of the quarter.
Strong organic growth in Norway
At the business area level, Norway stood out with organic growth of 11.2 percent. The new agreement in the assistance operations led to new customers and explains some of the growth. The segment for care homes is also growing. It is also worth noting that when it comes to our operations in Norway, the Hagen report on private welfare providers was published in December after two years of work. It will
contribute facts and knowledge to the debate on private welfare providers. The report acknowledges the role played by private welfare providers and shows that funds allocated to welfare is reaching the end users and that profit margins are reasonable, but it also highlights the importance of competence on the part of the contractors. The report is well worth reading by anyone interested in the future of welfare in the Nordics and the challenges it faces.
Newly established operations contribute
During the quarter, the Individual & Family business area noted its highest organic growth for an individual quarter in several years: 3.6 percent. The new operations in LSS and the adult segment are contributing, while demand in the child and youth segment remains stable. During the quarter, Individual & Family also acquired a company and we welcomed Team J-son in February, a provider of highquality care services for children and adolescents with complex needs with annual sales of SEK 90m.
Growth was also good in Personal Assistance for the quarter. The business area grew by 5 percent and also received high marks in our internal quality measurements thanks to good results in both the employee satisfaction survey as well as our customer satisfaction survey.
The Finnish operation is headed in the right direction operationally but faces several challenges. Both revenue and operating profit decreased in the quarter. The pandemic continues to have a negative effect on revenue due to lower occupancy in elderly and outpatient care. The reduction in revenue is also an effect of previous closings of units. In short, there remain financial challenges in Finland but the new management team has closed in on the problems and is now fully focused on taking corrective measures.
Pandemic remains main focus
Unfortunately, this is the fifth quarterly report in which I must state that the pandemic continues to be the main focus of our day-to-day activities, especially in elderly care. Since our elderly care residents as well as our employees have had the opportunity to be vaccinated, we see a clear and positive effect from the vaccinations. At the same time, vaccination is not a magic bullet, so the systematic preventive efforts linked to the pandemic in our operations must continue. The virus continues to spread in socitey as this is being written, so we must remain extra cautious. It is crucial that we not get distracted now. Our employee surveys show that the year has been challenging for our employees in elderly care, which underlines how important it is with a well-working and accessible leadership. That being said, there is also a lot of positive energy being generated in the operations. After the end of the quarter, in early April, the new elderly care home in Falkenberg opened and we welcomed many residents already in
the first month. In May and June we will open three more elderly care homes, in Vallentuna, Ängelhom and Norrtälje.
Humana's sustainability work gets attention
Finally, I would also like to recommend a look at our 2020 Annual and Sustainability Report, which was published in early April, and especially our expanded Sustainability Report. We have a lot left to do in the area of sustainability but also much to be proud of. The latter was confirmed by the Sustainable Brand Index, which is the largest independent brand study focused on sustainability in Europe and describes how consumers feel about a company's sustainability performance. It ranks Humana as the most sustainable brand in the health care providers category in Sweden for 2021. This pleases us but also places expectations on us.
Stockholm, 6 May 2021
Rasmus Nerman President and CEO, Humana AB
This is Humana
We drive the future of welfare
Humana is there for people with functional impairment, psychosocial disorders and mental illness and for the elderly. Our vision is Everyone is entitled to a good life. With assignments in hundreds of municipalities, 9,000 customers and clients, over 16,000 employees and several hundred units in Sweden, Finland, Norway and Denmark, we are a major provider in Nordic welfare. Humana manifests what quality care is all about. Our work is based on the individual's circumstances and needs. And our care is grounded in scientific evidence and the best available know-how, and is provided by knowledgeable, dedicated employees. Both our own and external surveys confirm that we succeed in what we do time and time again. But we won't stop there. Continuous development to maintain the highest quality is an essential aspect for us. We intend to set a new, higher standard of care. This is how we drive the future of Nordic care and welfare.
Everyone is entitled to a good life. Humana works to make this a reality.
Five business areas Operations in four countries
Strong market position in the Nordics
Humana is a Nordic care group with market-leading positions in individual and family care and personal assistance. We are growing in elderly care and are building new care homes under our own management.
16,717 employees 8,795
customers
7,797 revenue, SEK millions
Strategy for sustainable care
Humana's vision and overall objective deal with sustainability at an individual and societal level. Therefore, sustainability is an integral part of our strategy.
We have defined four strategic target areas: quality, attractiveness as an employer, profitable growth and social responsibility. These target areas, together with our core values, steer our business towards the vision that everyone is entitled to a good life.
OBJECTIVE
The obvious provider of care services for customers, clients and contractors with requirements for high quality.
STRATEGIC TARGET AREAS
QUALITY OPERATIONS ATTRACTIVE EMPLOYER
PROFITABLE GROWTH
Financial overview
Operating revenue by business area
| SEK millions | Jan–Mar 2021 |
Jan–Mar 2020 |
% | Apr–Mar 2020/21 |
Jan–Dec 2020 |
% |
|---|---|---|---|---|---|---|
| Individual & Family | 553 | 519 | 6% | 2,135 | 2,101 | 2% |
| Personal Assistance | 751 | 719 | 5% | 2,963 | 2,931 | 1% |
| Elderly Care | 151 | 146 | 3% | 612 | 608 | 1% |
| Finland | 316 | 350 | -10% | 1,293 | 1,327 | -3% |
| Norway | 210 | 194 | 8% | 804 | 788 | 2% |
| Other 1) | 5 | 10 | -50% | 38 | 43 | -11% |
| Total operating revenue | 1,986 | 1,938 | 2% | 7,845 | 7,797 | 1% |
Organic growth by business area
| Percent | Jan–Mar 2021 |
Jan–Mar 2020 |
Apr–Mar 2020/21 |
Jan–Dec 2020 |
|
|---|---|---|---|---|---|
| Individual & Family | 3.6% | 1.4% | 1.0% | 0.4% | |
| Personal Assistance | 2.5% | 2.9% | 4.0% | 4.1% | |
| Elderly Care | 3.1% | 9.0% | 6.3% | 7.7% | |
| Finland | -4.6% | 10.2% | -2.5% | 7.4% | |
| Norway | 11.2% | 4.6% | 10.9% | 8.9% | |
| Total organic growth | 2.4% | 3.8% | 2.9% | 4.1% |
Operating profit by business area
| SEK millions | Jan–Mar 2021 |
Jan–Mar 2020 |
% | Apr–Mar 2020/21 |
Jan–Dec 2020 |
% |
|---|---|---|---|---|---|---|
| Individual & Family | 41 | 33 | 24% | 198 | 190 | 4% |
| Personal Assistance | 50 | 40 | 23% | 169 | 160 | 6% |
| Elderly Care | 5 | 0 | n/a | 16 | 10 | 59% |
| Finland | 11 | 17 | -32% | 56 | 62 | -8% |
| Norway | 17 | 13 | 28% | 72 | 69 | 5% |
| Other 1) | -12 | -5 | -140% | -27 | -20 | -35% |
| Total operating profit | 112 | 98 | 14% | 485 | 471 | 3% |
Operating margins by business area
| Percent | Jan–Mar 2021 |
Jan–Mar 2020 |
Apr–Mar 2020/21 |
Jan–Dec 2020 |
|
|---|---|---|---|---|---|
| Individual & Family | 7.5% | 6.4% | 9.3% | 9.0% | |
| Personal Assistance | 6.6% | 5.6% | 5.7% | 5.5% | |
| Elderly Care | 3.6% | -0.3% | 2.6% | 1.6% | |
| Finland | 3.6% | 4.7% | 4.4% | 4.6% | |
| Norway | 7.9% | 6.7% | 9.0% | 8.7% | |
| Total operating margin | 5.7% | 5.1% | 6.2% | 6.0% |
1) Operating revenue and operating profit for the second quarter of 2020 include capital gain on sale of properties of SEK 17m.
Group development
Revenue
Operating revenue amounted to SEK 1,986m (1,938) in the first quarter, an increase of 2%. The organic revenue growth was 2.4% (3.8) for the quarter. Adjusted for leap day, organic growth amounted to 3.5% (2.7) in the first quarter. Improved organic growth in the Individual & Family and Norway business areas explain the organic growth.
Acquired operations accounted for SEK 29m of revenue. Operations under own management accounted for 94% of total revenue in the quarter and contracted operations accounted for 6%.
The Covid-19 pandemic had a negative impact on revenue largely due to lower occupancy in elderly care in Sweden and Finland and outpatient care in Finland.
Profit
Operating profit for the first quarter totaled SEK 112m (98), an increase of 14%. The operating margin was 5.7% (5.1). The improvement in profit and margin compared to the same period last year is attributable to all business areas except for Finland, which despite progress, did not contribute to the profit and margin increase.
The Covid-19 pandemic has affected the Group from several aspects. Lower occupancy had a negative effect on revenue while increased sickness absences and increased use of PPE resulted in higher costs. The increased costs were offset by lower social security costs, government support for sickness absence and partial compensation for PPE.
The effect on operating profit of accounting standard IFRS 16, which has been applied since 1 January 2019, amounted to SEK 15m in the quarter (see table).
| IFRS 16 effects, SEK millions | Jan–Mar 2021 |
Jan–Mar 2020 |
|---|---|---|
| Rental charges | 88 | 85 |
| Depreciation | -73 | -69 |
| Operating profit | 15 | 16 |
| Net financial effect | -20 | -20 |
| Profit before tax | -5 | -3 |
Operating cash flow and interest-bearing net debt
Operating cash flow in the first quarter amounted to SEK 197m (95). The increase is mostly attributable to improved profit, decreased working capital and lower investments.
Humana's interest-bearing net debt decreased by SEK 110m to SEK 3,688m (3,798). The decrease is mainly attributable to an increased operating cash flow offset by buyback of shares. The leverage ratio, i.e. interest-bearing net debt in relation to adjusted EBITDA, decreased to 4.4x (5.2), which means that Humana achieved the financial target.
In order to improve the capital structure, Humana repurchased shares of SEK 159m in the quarter. As of March 31, 2021, the holding of treasury shares amounts to 9.44% of the total number of outstanding shares corresponding to SEK 313m at cost. The repurchased shares have reduced cash and equity, which increases the company's interest-bearing net debt. In the future, the company's holding of own shares may ultimately be used as payment for or to finance acquisitions of companies and/or assets. They may also be cancelled.
Revenue
Operating profit
Performance by business area
Individual & Family
Revenue for the first quarter amounted to SEK 553m (519), an increase of 6% compared to the corresponding period last year. Organic growth was 3.6% (1.4). Adjusted for leap day, organic growth amounted to 4.8% (0.3) in the first quarter. Stable occupancy in the child and youth client group, increased occupancy in the adult segment, new units and acquisitions drove the revenue increase in the first quarter.
Operating profit for the first quarter totaled SEK 41m (33), an increase of 24% compared with the previous year. The operating margin for the first quarter was 7.5% (6.4). The increase in profit for the quarter is due to improved control and positive contributions from acquisitions. The increased costs associated with the Covid-19 pandemic in the quarter were compensated for by government grants.
Personal Assistance
Revenue increased by 5% to SEK 751m (719) in the first quarter. Organic growth was 2.5% (2.9). Adjusted for leap day, organic growth amounted to 3.6% (1.8) in the first quarter. Other than acquired operations, the revenue increase is mainly due to a higher attendance allowance.
Operating profit for the quarter totaled SEK 50m (40), an increase of 23%. The operating margin was 6.6% (5.6). The operating margin increased due to more efficient cost management and positive contributions from acquisitions.
Percentage of Group revenue Q1 2021
Operating revenue and operating margin
Percentage of Group revenue Q1 2021
Operating revenue and operating margin
Elderly Care
Revenue amounted to SEK 151m (146) in the first quarter. The 3% (9.0) increase is entirely organic. Adjusted for leap day, organic growth amounted to 4.3% (7.8) in the first quarter. The increase is due entirely to contracted operations. The pandemic had a negative effect on occupancy this quarter as well.
Operating profit in the first quarter amounted to SEK 5m (0). The operating margin was 3.6% (-0.3). Improvements in new units had positive effects.
The pandemic has affected the result through lower occupancy and higher costs for sick leave and PPE, personal protective equipment. The higher costs have been partially offset by government grants.
Finland
Revenue amounted to SEK 316m (350) in the first quarter, a decrease of 10%. Organic growth was -4.6% (10.2). Adjusted for leap day, organic growth amounted to -3.6% (9.0) in the first quarter. The decrease in revenue was impacted by terminated unprofitable contracts. The pandemic also had a negative impact in elderly care and outpatient care. New unit openings had a positive effect but did not fully compensate for the decrease in revenue.
Operating profit for the first quarter amounted to SEK 11m (17), a decrease of 32% compared to the corresponding period last year. The operating margin for the quarter was 3.6% (4.7). The lower profit for the quarter was partly driven by the negative effects of the pandemic on occupancy and increased costs for sick leave.
Percentage of Group revenue Q1 2021
Operating revenue and operating margin
Percentage of Group revenue Q1 2021
Operating revenue and operating margin
Norway
Revenue increased by 8% to SEK 210m (194) in the first quarter. Organic revenue growth was 11.2% (4.6) for the quarter. Adjusted for leap day, organic growth amounted to 12.5% (3.4) in the first quarter. The revenue increase and organic growth are mainly due to an increase in customers in personal assistance and the care home segment.
Operating profit for the quarter amounted to SEK 17m (13), a year-on-year increase of 28%. The operating margin for the quarter was 7.9% (6.7). The improved operating margin for the quarter is due to an increased number of customers and higher operational efficiency.
Percentage of Group revenue Q1 2021
Operating revenue and operating margin
Financial position
Financing
The Group's equity amounted to SEK 2,282m (2,368) on 31 March 2021. The equity/assets ratio was 28.3% (28.4). Interest-bearing net debt amounted to SEK 3,688m (3,798), a year-on-year decrease of SEK 110m. The leverage ratio, measured as interest-bearing net debt in relation to adjusted EBITDA, decreased to 4.4x (5.2). The decrease is mainly due to higher profit and fewer investments.
| SEK millions | 31 Mar 2021 | 31 Mar 2020 | 31 Dec 2020 |
|---|---|---|---|
| Non-current interest-bearing liabilities | 1,970 | 3,695 | 3,457 |
| Current interest-bearing liabilities | 2,307 | 892 | 813 |
| Cash and cash equivalents | -589 | -789 | -759 |
| Interest-bearing net debt |
3,688 | 3,798 | 3,511 |
| Equity/assets ratio | 28.3% | 28.4% | 29.3% |
| Interest-bearing net debt/adjusted EBITDA, 12 months, times |
4.4x | 5.2x | 4.3x |
Cash flow
Cash flow for the quarter amounted to SEK -196m (-58), where net cash flow from operating activities was SEK 169m (94). The higher cash flow from operating activities is mainly due to increased profit and decreased working capital compared to last year.
Cash flow from investing activities in the quarter amounted to SEK -82m (-31), of which SEK -59m related to acquisitions in the quarter, while the first quarter last year was affected positively by sale of real estate. Cash flow from financing activities was SEK -283m (-121). The change is due to the buyback of shares for SEK 159m.
Financial targets
Profitability
An operating margin of 7% over the medium term.
Revenue growth
Annual organic revenue growth of 5% over the medium term. Bolt-on acquisitions may generate additional annual growth of 2-3%.
Capital structure
Interest-bearing net debt not exceeding 4.5 times EBITDA, i.e. operating profit before depreciation, amortisation and impairment (see Financial definitions and intent). Debt may temporarily exceed the target level, which may happen during acquisitions.
Dividend policy
Payment of a dividend equivalent to 30% of net profit for the year. The proposed dividend shall consider Humana's long-term development potential and financial position.
Sustainability
Quality Report, first quarter, January–March 2021
Humana Quality Model and quality at Humana
Humana is convinced that quality needs to be measured and followed up. Measuring and following up helps to develop our operations and to always keep high quality in focus. To measure quality within the Group and be able to compare various operations and see changes over time, Humana has developed the Humana Quality Model (HQM). The model is built on two parallel approaches: seven quantitative indicators that are weighed together to form the Humana Quality Index (HQI) along with qualitative and quantitative following up of customers'/clients' individual plans and the personal goals that guide them. Both perspectives are equally important in creating an overall assessment of quality. Follow-ups are done quarterly. Humana has presented the quality report on our website since 2019.
Humana Quality Index
All business areas continue to work hard to prevent the spread of Covid-19 and we have managed to keep transmission at a low level. Vaccination is ongoing, and in both elderly care and LSS homes in Sweden, all residents who want the vaccine have received their second injection. Even so, we continue to maintain a high level of protection. The danger is not over, and we believe that we need to keep vigilant for a good while yet.
After six months at the record level of 95/100, the HQI for the Group at large decreased by one point during the quarter to 94/100, where 100 is the longterm target. The Personal Assistance business area increased its level by two points to a new record of 98/100 thanks to good results in the employee survey and the customer survey. At the same time, the levels of the Elderly Care and Finland business areas decreased somewhat due to lower results in the employee survey. After several years of good results in elderly care, the initial analyses indicate that the less favorable result is due to the exceptionally strenuous effects of the 2020 pandemic year. The year was strenuous both physically and mentally, and many were negatively affected by the mostly negative criticism directed at elderly care over the course of the year.
The number of serious deviations decreased during the quarter compared with the previous quarter. Three Lex Sarah and one Lex Maria case were submitted to the Health and Social Care Inspectorate (IVO).
Follow-up of individual plans
The number of individual plans that were followed up as scheduled was unchanged for the quarter at 85/100 compared with the previous quarter. This is a reduction compared with the full year result from 2020.
Here, there are also differences between business areas. Individual & Family increased slightly to 95/100 for the quarter, while the Norway business area decreased slightly from its record level of last autumn to a still high 93/100. Personal Assistance has a way to go yet to assure the individual plans and remains at the same level as last quarter: 71/100. Generally, the individual plans constitute an area that is important to continue improving.
It is important that an individual plan is prepared for all customers and clients. In Sweden this is called an implementation plan. We count the number of customers/clients who have an individual plan that has been prepared and followed up. The individual plan and its goals form the foundation of the quality control.
Humana Quality Index
Personal data breaches
Three personal data breaches were reported to the Swedish Authority for Privacy Protection (IMY) in the first quarter. No incidents were reported in other countries.
Everyone that comes into contact with Humana should feel that their personal data is secure with us. We are transparent about the data we handle and why. Read more about GDPR at Humana here:
https://www.humanagroup.com/media/gdpr-humana
Read about sustainability at Humana
Quality is one of the four strategic target areas that form the basis for Humana's sustainable care strategy. Other target areas are attractive employer, profitable growth and socially responsible provider, which includes environmental responsibility. Read more about Humana's sustainable strategy, our four strategic target areas and our sustainability work on our website at https://www.humanagroup.com/sustainability/
Other information
Employees
The number of full-time employees as of 31 March 2021 was 10,231 (9,997).
Shares, share capital and shareholders
The number of shares in Humana AB as per 31 March 2021 amounted to 53,140,064 with a quotient value of SEK 0.022, corresponding to share capital of SEK 1,180,879. The number of shareholders was 4,683. The five largest shareholders were Impilo Care AB, Incentive AS (via funds and mandate), SEB Investment Management, Alcur Fonder and Nordea Investment Funds.
Share buybacks
At the 2020 AGM, the Board was mandated to repurchase shares as long as the company's total holdings of own shares does not exceed one-tenth of all shares in the company and to transfer own shares in the company. In February and March 2021, Humana repurchased 2,357,348 shares at a cost of SEK 159m, corresponding to an average price of SEK 67.51 per share. Subsequently, the company's total own shareholding amounts to 5,017,059 shares, which is 9.44 percent of the total number of outstanding shares and votes. After repurchases, the total number of shares excluding the own holding amounts to 48,123,005.
Marketplace
Humana's shares trade on the Nasdaq Stockholm Main Market. The company's ticker symbol is HUM and the ISIN code is SE0008040653.
Share-based incentive programmes
Humana has no ongoing long-term share-related incentive programme for senior executives or other employees.
In June 2020, Impilo Care AB, Humana's principal owner, made an offer to Board members and senior executives of Humana to acquire synthetic options in Humana issued by Impilo Care AB. Humana did not participate in the offer and it will not give rise to any costs for Humana. A total of 461,000 synthetic options were acquired. The total market value of the options on the transaction date is estimated at approximately SEK 1.4m. The synthetic options are related to Humana's share and expire after three years. The options can be exercised from 1 April 2023 to 30 June 2023. The exercise price is SEK 77.90 per option.
Annual General Meeting
Humana's 2021 Annual General Meeting (AGM) will be held on Tuesday 11 May at 15:00 CET. Due to the extraordinary situation caused by the Covid-19 pandemic, the meeting will be held in a different manner than usual. To reduce the risk of transmission and considering official regulations and advice on avoidance of gatherings, the meeting will be held, supported by temporary statutory provisions, through absentee voting (postal voting). There will be no meeting in person or through a proxy, i.e., there will be no physical participation.
Dividend
Humana's Board proposes to the 2021 AGM that no dividend be paid for the 2020 financial year and that any profits be carried forward.
Annual and Sustainability Report
The 2020 Annual and Sustainability Report is available on Humana's website at https://www.humanagroup.com/
Related party transactions
The Group's key personnel consists of the Board of Directors, Group management and the CEO, through ownership of the company and through their roles as senior executives. Related party transactions are based on market conditions.
Risks and uncertainties
In the course of its operations, Humana is exposed to different types of financial risks, which can be divided into liquidity and funding risk, interest rate risk, credit risk and currency risk. Risks are described in more detail in the section in Humana's 2020 annual and sustainability report entitled Risks and risk management on pages 64–71 as well as in Note G20.
The main risks related to operations and uncertainties that can affect the company's performance are related to political decisions that may affect private care companies, as well as risks when implementing completed acquisitions. Humana conducts operations that are financed by state, municipal and regional entities, and as such, operations can be affected by political decisions. As a result, Humana's opportunities for growth are affected by public opinion and political views on the company's areas of operation. Humana is constantly monitoring the external situation. The purpose is to quickly perceive external changes in order to assess risks and opportunities, as well as adapt operations to external changes. The political situation is evaluated continuously.
Communicable diseases exist in society. These infections can affect anyone in society but the situation is most difficult for vulnerable persons. Humana's operations include customers and clients in vulnerable groups and there are guidelines and procedures in the company's management system on how to prevent and manage various communicable diseases. Communicable diseases may also lead to several employees getting sick at the same time, which entails a risk of not having enough qualified staff to meet needs. A pandemic also entails a risk of a negative impact on Humana's revenues and costs, for example as a result of lower occupancy or increased costs for sickness absences and PPE. Humana's operations are affected by the prevailing Covid-19 pandemic. A crisis management structure has been supporting the work of minimising transmission and impact since the pandemic began.
This interim report was not subject to a review as per ISRE 2410 by the company's auditors.
The President certifies that this interim report for the first quarter gives a true and fair presentation of the Parent Company's and Group's business, financial position and result of operations, and describes the material risks and uncertainties facing the Parent Company and the Group.
Stockholm, 6 May 2021
Rasmus Nerman President and CEO
Consolidated income statement
| Jan–Mar | Jan–Mar | Apr–Mar | Jan–Dec | |
|---|---|---|---|---|
| SEK millions Note |
2021 | 2020 | 2020/21 | 2020 |
| Net revenue | 1,984 | 1,932 | 7,822 | 7,771 |
| Other operating revenue | 2 | 6 | 22 | 26 |
| Operating revenue 3.4 |
1,986 | 1,938 | 7,845 | 7,797 |
| Other external expenses | -229 | -240 | -902 | -913 |
| Personnel costs | 1,554 | -1,511 | -6,083 | -6,039 |
| Depreciation/amortisation | -91 | -88 | -374 | -371 |
| Other operating expenses | 0 | -1 | -2 | -2 |
| Operating expenses | -1,874 | -1,840 | -7,360 | -7,326 |
| Operating profit | 112 | 98 | 485 | 471 |
| Financial income | 2 | 4 | 4 | 6 |
| Financial expenses | -35 | -38 | -142 | -145 |
| Profit before tax | 79 | 64 | 346 | 332 |
| Income tax | -16 | -11 | -75 | -70 |
| Net profit for the period | 63 | 53 | 271 | 262 |
| Attributable to: | ||||
| Parent Company shareholders | 63 | 53 | 271 | 262 |
| Non-controlling interests | - | 0 | 0 | 0 |
| Net profit for the period | 63 | 53 | 271 | 262 |
| Earnings per share, SEK, before dilution | 1.27 | 1.00 | 5.21 | 4.94 |
| Earnings per share, SEK, after dilution | 1.27 | 1.00 | 5.21 | 4.94 |
| Average number of shares, thousands | 49,415 | 53,140 | 52,061 | 52,995 |
Consolidated statement of other comprehensive income
| Jan–Mar | Jan–Mar | Apr–Mar | Jan–Dec | |
|---|---|---|---|---|
| 2020 | ||||
| 63 | 53 | 271 | 262 | |
| 6 | -24 | 5 | 10 | 39 |
| 49 | 5 | -31 | -74 | |
| 87 | 63 | 251 | 227 | |
| 87 | 63 | 251 | 227 | |
| - | 0 | 0 | 0 | |
| Note | 2021 | 2020 | 2020/21 |
Condensed consolidated balance sheet
| SEK millions Note |
31 Mar 2021 | 31 Mar 2020 | 31 Dec 2020 |
|---|---|---|---|
| Assets | |||
| Non-current assets | |||
| Goodwill | 5 3,925 |
3,923 | 3,815 |
| Other intangible assets | 13 | 6 | 5 |
| Property, plant and equipment | 322 | 391 | 314 |
| Right-of-use assets | 2,130 | 2,141 | 2,119 |
| Financial assets | 43 | 37 | 42 |
| Total non-current assets | 6,434 | 6,497 | 6,295 |
| Current assets | |||
| Trade receivables and other receivables | 865 | 838 | 852 |
| Other current receivables | 165 | 215 | 138 |
| Cash and cash equivalents | 589 | 789 | 759 |
| Total current assets | 1,619 | 1,842 | 1,749 |
| TOTAL ASSETS | 8,052 | 8,340 | 8,044 |
| Equity and liabilities | |||
| Equity | |||
| Share capital | 1 | 1 | 1 |
| Other paid-in equity | 1,096 | 1,096 | 1,096 |
| Reserves | 19 | 38 | -6 |
| Retained earnings | 1,167 | 1,211 | 1,264 |
| Equity attributable to Parent Company shareholders | 2,282 | 2,346 | 2,354 |
| Equity attributable to non-controlling interests | - | 22 | - |
| Total equity | 2,282 | 2,368 | 2,354 |
| Non-current liabilities | |||
| Non-current lease liabilities | 1,970 | 1,959 | 1,958 |
| Other interest-bearing liabilities | - | 1,736 | 1,499 |
| Deferred tax liabilities | 72 | 71 | 70 |
| Total non-current liabilities | 2,042 | 3,766 | 3,527 |
| Current liabilities | |||
| Current lease liabilities | 236 | 271 | 232 |
| Other interest-bearing liabilities | 2,071 | 620 | 581 |
| Trade payables | 111 | 91 | 128 |
| Other current liabilities | 6 1,310 |
1,223 | 1,222 |
| Total current liabilities | 3,728 | 2,206 | 2,163 |
| TOTAL EQUITY AND LIABILITIES | 8,052 | 8,340 | 8,044 |
Condensed consolidated statement of changes in equity
| Equity attributable to |
|||||||
|---|---|---|---|---|---|---|---|
| Other | Parent | Non | |||||
| SEK millions | Share capital |
paid-in capital |
Translation reserve |
Retained earnings |
Company shareholders |
controlling interests |
Total equity |
| Opening balance, 1 Jan 2020 | 1 | 1,096 | 29 | 1,158 | 2,284 | 22 | 2,305 |
| Comprehensive income for the period |
|||||||
| Net profit for the period | - | - | - | 53 | 53 | 0 | 53 |
| Other comprehensive income for the period |
- | - | 10 | - | 10 | - | 10 |
| Total comprehensive income for the period |
- | - | 10 | 53 | 63 | 0 | 63 |
| Closing balance, 31 Mar 2020 | 1 | 1,096 | 38 | 1,211 | 2,346 | 22 | 2,368 |
| Opening balance, 1 Jan 2021 | 1 | 1,096 | -6 | 1,264 | 2,354 | - | 2,354 |
| Comprehensive income for the period |
|||||||
| Net profit for the period | - | - | - | 63 | 63 | - | 63 |
| Other comprehensive income for the period |
- | - | 25 | - | 25 | - | 25 |
| Total comprehensive income for the period |
- | - | 25 | 63 | 88 | - | 88 |
| Owner transactions | |||||||
| Share buybacks | - | - | - | -159 | -159 | - | -159 |
| Total owner transactions | - | - | - | -159 | -159 | - | -159 |
| Closing balance, 31 Mar 2021 | 1 | 1,096 | 19 | 1,167 | 2,282 | - | 2,282 |
Condensed consolidated statement of cash flows
| SEK millions | Note | Jan–Mar 2021 | Jan–Mar 2020 | Apr–Mar 2020/21 | Jan–Dec 2020 |
|---|---|---|---|---|---|
| Profit before tax | 79 | 64 | 346 | 332 | |
| Adjustments for: | |||||
| Depreciation/amortisation | 91 | 88 | 374 | 371 | |
| Financial items, net | 33 | 34 | 138 | 139 | |
| Capital gain on sale of property, plant and equipment |
-1 | 0 | -19 | -17 | |
| Cash flow from operating activities before change in working capital |
202 | 187 | 839 | 824 | |
| Change in working capital | 23 | -41 | 134 | 71 | |
| Cash flow from operating activities | 225 | 146 | 973 | 895 | |
| Financial items paid, net | -30 | -30 | -144 | -143 | |
| Income tax paid | -26 | -23 | -93 | -90 | |
| Net cash flow from operating activities | 169 | 94 | 736 | 661 | |
| Acquisition of subsidiaries, net cash impact | 5 | -59 | 0 | -77 | -18 |
| Disposal of properties | 6 | 20 | 101 | 114 | |
| Investments in other non-current assets, net | -29 | -51 | -111 | -133 | |
| Cash flow from investing activities | -82 | -31 | -87 | -37 | |
| Loans raised | 0 | 0 | 23 | 24 | |
| Repayment of borrowings | -50 | -50 | -251 | -251 | |
| Repayment of lease liability | -73 | -71 | -287 | -284 | |
| Share buybacks | -159 | - | -315 | -156 | |
| Cash flow from financing activities | -283 | -121 | -829 | -667 | |
| Cash flow for the period | -196 | -58 | -180 | -42 | |
| Cash and cash equivalents, opening balance |
759 | 836 | 789 | 836 | |
| Exchange rate difference in cash and cash equivalents |
26 | 11 | -21 | -35 | |
| Cash and cash equivalents, closing balance |
589 | 789 | 589 | 759 |
Key ratios
| Jan–Mar 2021 | Jan–Mar 2020 Apr–Mar 2020/21 | Jan–Dec 2020 | ||
|---|---|---|---|---|
| Operating revenue | 1,986 | 1,938 | 7,845 | 7,797 |
| Operating margin, % | 5.7% | 5.1% | 6.2% | 6.0% |
| Interest-bearing net debt, SEKm | 3,688 | 3,798 | 3,688 | 3,511 |
| Return on capital employed, % | 1.7% | 1.4% | 7.4% | 7.1% |
| Equity/assets ratio, % | 28.3% | 28.4% | 28.3% | 29.3% |
| Operating cash flow, SEKm | 197 | 95 | 881 | 779 |
| Interest-bearing net debt/adjusted EBITDA, 12 months, times |
4.4x | 5.2x | 4.4x | 4.3x |
| Average number of full-time employees, Individual and Family |
2,105 | 2,085 | 2,070 | 2,065 |
| Average full-time employees, Personal Assistance | 5,029 | 4,887 | 5,135 | 5,099 |
| Average full-time employees, Elderly Care | 954 | 820 | 895 | 862 |
| Average full-time employees, Finland | 1,619 | 1,681 | 1,654 | 1,669 |
| Average full-time employees, Norway | 960 | 779 | 932 | 838 |
| Average full-time employees, Central Functions, including Denmark |
63 | 57 | 61 | 59 |
| Total average full-time employees | 10,731 | 10,309 | 10,746 | 10,592 |
| Full-time employees at end of period | 10,231 | 9,997 | 10,231 | 10,639 |
| Average number of customers, Individual & Family | 1,804 | 1,760 | 1,757 | 1,746 |
| Average number of customers, Personal Assistance | 1,878 | 1,885 | 1,891 | 1,893 |
| Average number of customers, Elderly Care | 837 | 803 | 833 | 825 |
| Average number of customers, Finland | 3,924 | 4,265 | 3,862 | 3,947 |
| Average number of customers, Norway | 358 | 312 | 328 | 317 |
| Average number of customers, Denmark | 67 | 69 | 68 | 68 |
| Total average number of customers | 8,868 | 9,094 | 8,739 | 8,795 |
| Average number of shares for period, thousands | 49,415 | 53,140 | 52,061 | 52,995 |
| Equity per share, SEK | 43 | 44 | 44 | 44 |
| Earnings per share, SEK, after dilution | 1.27 | 1.00 | 5.21 | 4.94 |
Parent Company
Condensed income statement
| SEK millions | Jan–Mar 2021 | Jan–Mar 2020 | Apr–Mar 2020/21 | Jan–Dec 2020 |
|---|---|---|---|---|
| Operating revenue | 0 | 2 | 0 | 2 |
| Operating expenses | -5 | -5 | -17 | -17 |
| Operating profit | -5 | -3 | -17 | -15 |
| Interest income | 1 | 32 | 77 | 108 |
| Interest expenses | -41 | -39 | -110 | -108 |
| Profit after financial items | -45 | -10 | -50 | -15 |
| Group contributions | - | - | 105 | 105 |
| Change in untaxed reserves | - | - | 4 | 4 |
| Profit before tax | -45 | -10 | 59 | 94 |
| Income tax | 9 | 2 | -17 | -25 |
| Net profit for the period | -36 | -8 | 41 | 69 |
Condensed balance sheet
| SEK millions | 31 Mar 2021 | 31 Mar 2020 | 31 Dec 2020 |
|---|---|---|---|
| Non-current assets | 1,629 | 1,629 | 1,629 |
| Current assets | 1,401 | 1,921 | 1,616 |
| TOTAL ASSETS | 3,030 | 3,550 | 3,244 |
| Equity | 1,377 | 1,651 | 1,572 |
| Untaxed reserves | 148 | 152 | 148 |
| Non-current interest-bearing liabilities | 0 | 1,123 | 946 |
| Other current liabilities | 1,506 | 624 | 578 |
| TOTAL EQUITY AND LIABILITIES | 3,030 | 3,550 | 3,244 |
Notes
Note 1 Accounting policies
This interim report has been prepared in accordance with IAS 34 Interim Financial Reporting along with applicable stipulations in the Swedish Annual Accounts Act. The interim report for the Parent Company has been prepared in accordance with Chapter 9 of the Swedish Annual Accounts Act – Interim Reports. In general, the same accounting policies and bases of calculation have been used as in the annual report for 2020, which was prepared in accordance with the International Financial Reporting Standards as ratified by the EU, and interpretations of these.
Disclosures in accordance with IAS 34.16A appear in the financial statements and their associated notes as well as in the interim information on pages 2–8, which form an integral part of this financial report.
New accounting standards applied from 1 January 2021
Humana has made the assessment that new or amended standards and interpretations will not have any significant effect on the consolidated financial statements.
Note 2 Estimations and assessments
Preparation of interim financial statements in compliance with IFRS requires management to make accounting estimates and assumptions which affect the application of the accounting policies and the carrying amounts of assets, liabilities, income and expenses. The actual outcome may differ from these accounting estimates and assessments. The critical assessments and sources of uncertainty in estimates are the same as in the most recent annual report.
Note 3 Operating segments
| Individual & Family | Personal Assistance | Elderly Care | ||||
|---|---|---|---|---|---|---|
| SEK millions | Jan–Mar 2021 |
Jan–Mar 2020 |
Jan–Mar 2021 |
Jan–Mar 2020 |
Jan–Mar 2021 |
Jan–Mar 2020 |
| Net revenue – External income | 553 | 519 | 751 | 719 | 151 | 146 |
| Other operating revenue | - | - | - | - | - | - |
| Operating revenue | 553 | 519 | 751 | 719 | 151 | 146 |
| Profit before depreciation, amortisation and other operating expenses |
50 | 42 | 50 | 41 | 8 | 3 |
| Depreciation/amortisation | -9 | -8 | 0 | 0 | -3 | -3 |
| Other operating expenses | - | -1 | - | - | - | - |
| Operating profit | 41 | 33 | 50 | 40 | 5 | 0 |
| Finland | Norway | Other | Total | |||||
|---|---|---|---|---|---|---|---|---|
| Jan–Mar | Jan–Mar | Jan–Mar | Jan–Mar | Jan–Mar | Jan–Mar | Jan–Mar | Jan–Mar | |
| SEK millions | 2021 | 2020 | 2021 | 2020 | 2021 | 2020 | 2021 | 2020 |
| Net revenue – External income | 316 | 350 | 208 | 194 | 5 | 4 | 1,984 | 1,932 |
| Other operating revenue | 0 | 0 | 2 | 0 | 0 | 6 | 2 | 6 |
| Operating revenue | 316 | 350 | 210 | 194 | 5 | 10 | 1,986 | 1,938 |
| Profit before depreciation, | ||||||||
| amortisation and other | 15 | 21 | 18 | 16 | 62 | 65 | 203 | 187 |
| operating expenses | ||||||||
| Depreciation/amortisation | -4 | -4 | -2 | -3 | -73 | -70 | -91 | -88 |
| Other operating expenses | - | - | - | - | - | - | - | -1 |
| Operating profit | 11 | 17 | 17 | 13 | -12 | -5 | 112 | 98 |
Note 4 Revenue by country
| SEK millions | Jan–Mar 2021 |
Jan–Mar 2020 |
|---|---|---|
| Sweden | 1,455 | 1,390 |
| Finland | 316 | 350 |
| Norway | 210 | 194 |
| Denmark | 4 | 4 |
| Total operating revenue | 1,986 | 1,938 |
Note 5 Acquisitions
Net assets in acquired companies at date of acquisition
| SEK millions | Team J-son |
|---|---|
| Non-current assets | 0 |
| Current assets | 27 |
| Non-current liabilities | - |
| Current liabilities | -11 |
| Net identifiable assets and liabilities | 17 |
| Goodwill | 63 |
| Total consideration | 80 |
| Contingent consideration | -1 |
| Consideration not yet settled | -1 |
| Cash and cash equivalents in acquired entities | -20 |
| Effect on cash and cash equivalents | 58 |
| Other | |
|---|---|
| Settlement of considerations attributable to prior acquisitions |
1 |
| Total effect on cash and cash equivalents | 59 |
1)The acquisition analysis is preliminary as the final settlement has not been determined.
Humana's acquisitions in the first quarter 2021 increased the Group's revenue by SEK 15 million and had an effect of SEK 1 million on operating profit for the quarter. If the acquisition had occurred as at 1 January 2021, the consolidated revenue would have been SEK 1,993 million (SEK 7 million higher) and profit for the period would have been SEK 62,5 million (SEK 0,5 million lower).
Note 6 Fair value of financial instruments and level in valuation hierarchy
| 31 Mar 2021 SEK millions |
Financial liabilities at fair value through profit or loss |
Total carrying amounts |
Fair values |
Level 1 | Level 2 | Level 3 |
|---|---|---|---|---|---|---|
| Financial liabilities | ||||||
| Earn-out payment | 6 | 6 | 6 | - | - | 6 |
| 31 Mar 2020 | Financial liabilities at fair value through |
Total carrying | Fair |
| SEK millions | profit or loss | amounts | values | Level 1 | Level 2 | Level 3 |
|---|---|---|---|---|---|---|
| Financial liabilities | ||||||
| Earn-out payment | 13 | 13 | 13 | - | - | 13 |
Fair value measurement
When determining the fair value of an asset or liability, the Group uses observable data as far as possible. Fair value is categorised in various levels in a fair value hierarchy based on input data that is used in the valuation method as follows:
Level 1: according to prices quoted in an active market for the same instruments
Level 2: based on directly or indirectly observable market data that is not included in level 1
Level 3: inputs that are not observable in the market
Reconciliation of opening/closing balances for financial instruments measured in level 3, earn-out payment
| SEK millions | 31 Mar 2021 | 31 Dec 2020 |
|---|---|---|
| Opening balance, 1 January | 6 | 13 |
| Total recognised gains and losses: | ||
| Recognised in adjustment of earn-out payments in net profit | 0 | 0 |
| Cost of acquisition | 1 | 1 |
| Settled during the period | -1 | -8 |
| Closing balance, end of period | 6 | 6 |
Hedge accounting
The Group is hedging parts of the foreign exchange risk related to net investments in foreign operations. As at 31 March 2021, the Group had exposure to EUR, NOK and DKK. DKK makes up a small amount and is not hedged. NOK and EUR are hedged using loans in foreign currency. Hedge accounting entails recognising the effective part of the translation differences in the consolidated statement of other comprehensive income. As at 31 March 2021, the Group had loans of EUR 40m and loans of NOK 328m for which hedge accounting is applied. The related translation difference of SEK -30m (7) before tax is consequently recognised in the consolidated statement of other comprehensive income.
Reconciliation of financial statements with IFRS
In the financial reports that Humana issues, there are alternative performance measures specified that complement the measurements defined or specified in the applicable financial reporting rules. Alternative performance measures are indicated when, in their context, they provide clearer or more detailed information than the measurements defined in the applicable financial reporting rules. Alternative performance measures derive from the company's consolidated accounts and are not measures in accordance with IFRS.
| SEK millions | Jan–Mar 2021 | Jan–Mar 2020 | Apr–Mar 2020/21 | Jan–Dec 2020 |
|---|---|---|---|---|
| Adjusted operating profit | ||||
| Operating profit | 112 | 98 | 485 | 471 |
| Capital gain on sale of property | 0 | 0 | -17 | -17 |
| Adjusted operating profit | 112 | 98 | 467 | 453 |
| Adjusted EBITDA | ||||
| Operating profit | 112 | 98 | 485 | 471 |
| Depreciation/amortisation | 91 | 88 | 374 | 371 |
| EBITDA | 203 | 187 | 858 | 842 |
| Capital gain on sale of property | 0 | 0 | -17 | -17 |
| Adjusted EBITDA | 203 | 187 | 841 | 824 |
| Organic revenue growth | ||||
| Revenue, base | 1,932 | 1,708 | 7,615 | 6,968 |
| Revenue, organic growth | 47 | 65 | 220 | 289 |
| Total organic growth | 2.4% | 3.8% | 2.9% | 4.1% |
| Operating cash flow | ||||
| Operating profit | 112 | 98 | 485 | 471 |
| Depreciation/amortisation | 91 | 88 | 374 | 371 |
| Change in working capital | 23 | -41 | 134 | 71 |
| Investments in other non-current assets, net | -29 | -51 | -111 | -133 |
| Operating cash flow | 197 | 95 | 881 | 779 |
| 31 Mar 2021 | 31 Mar 2020 | 31 Dec 2020 | |
|---|---|---|---|
| Interest-bearing net debt | |||
| Non-current interest-bearing liabilities | 1,970 | 3,695 | 3,457 |
| Current interest-bearing liabilities | 2,307 | 891 | 813 |
| Cash and cash equivalents | -589 | -789 | -759 |
| Interest-bearing net debt | 3,688 | 3,798 | 3,511 |
| Adjusted EBITDA, 12 months | 841 | 734 | 824 |
| Interest-bearing net debt/Adjusted EBITDA, 12 months, times |
4.4x | 5.2x | 4.3x |
| Return on capital employed, % | |||
| Total assets | 8,052 | 8,340 | 8,044 |
| Deferred tax liabilities | -72 | -71 | -70 |
| Trade payables | -111 | -91 | -128 |
| Other current liabilities | -1,310 | -1,223 | -1,222 |
| Capital employed | 6,559 | 6,955 | 6,624 |
| Operating profit | 112 | 98 | 471 |
| Financial income | 0 | 0 | 1 |
| Total | 112 | 99 | 471 |
| Return on capital employed, % | 1.7% | 1.4% | 7.1% |
| Equity/assets ratio, % | |||
| Total equity | 2,282 | 2,368 | 2,354 |
| Total assets | 8,052 | 8,340 | 8,044 |
| Equity/assets ratio, % | 28.3% | 28.4% | 29.3% |
Financial definitions and intent
Financial performance measures
| Definition | Intent | |
|---|---|---|
| Return on capital employed (%) |
Operating profit and financial income divided by total capital employed multiplied by 100. |
Indicates the operating return on the capital that owners and lenders have made available. The intent is to show consolidated returns, regardless of the financing. |
| EBITDA | Operating profit before depreciation, amortisation and impairment. |
The measure is used to monitor the company's profit/loss generated by operating activities and facilitate comparisons of profitability between different companies and industries. |
| Adjusted operating profit and adjusted EBITDA |
Operating profit and EBITDA adjusted for items affecting comparability. |
Adjustment for non-recurring items is made to facilitate a fair comparison between two comparable periods and to show the underlying trend in operating activities excluding non-recurring items. |
| Operating cash flow |
Operating profit including changes in depreciation/amortisation/impairment, working capital and investments in other assets (net). |
The exclusion of cash flow from acquisitions and financing facilitates an analysis of cash conversion in operating activities. |
| Organic growth | Growth in local currency for comparable companies in each segment that Humana owned during the previous comparative period. |
The measure shows the underlying sales growth in comparable companies between the different periods. |
| Interest bearing net debt |
Borrowing excluding interest rate derivatives less cash and cash equivalents and interest-bearing assets. |
Net debt is used as a simple way to illustrate and assess the Group's ability to meet financial commitments. |
| Interest bearing net debt/adjusted EBITDA |
Interest-bearing net debt divided by adjusted EBITDA. |
The measure indicates consolidated debt in relation to adjusted EBITDA. This is used to illustrate the Group's ability to meet financial commitments. |
| Equity/assets ratio (%) |
Equity including non-controlling interests divided by total assets multiplied by 100. |
Indicates the proportion of assets that are financed with equity. The aim is to assess the Group's solvency in the long term. |
| Capital employed |
Total assets less non-interest-bearing liabilities. |
The measure indicates the portion of the company's assets financed by interest-bearing capital. |
Other performance measures
| Definition | |
|---|---|
| Equity per share | Equity attributable to Parent Company shareholders divided by number of shares at end of period after redemption, buyback and new share issue. |
| Average number of shares | Calculated as the average daily number of shares outstanding after redemption and buyback. |
| Items affecting comparability | Non-recurring items that complicate the comparability between two given periods. |
| Average number of full-time employees |
Average number of full-time employees during the reporting period. |
| Average customers | Average number of customers during the period. |
| Earnings per share for the period | Profit for the period attributable to Parent Company shareholders less the period's share of the adopted dividend divided by average number of shares. |
| Operating profit | Profit before financial items and tax. |
| EBIT margin (%) | Operating profit divided by operating revenue multiplied by 100. |
This information is information that Humana AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out below, on 6 May 2021 at 08:00 CET.
A web-based teleconference will be held on 6 May 2021 at 09:00 CET at which President and CEO Rasmus Nerman and CFO Noora Jayasekara will present the report and answer questions. To participate, call: SE: +46 8 5664 2693 UK: +44 33 3300 9260 US: +1 844 625 1570
Conference call Financial calendar Contact
2021 Annual General Meeting Half-year report Jan–Jun, Q2 2021 Interim report Jan–Sep, Q3 2021 11 May 2021 20 Aug 2021 11 Nov 2021
Noora Jayasekara, CFO +46 70 318 92 97 [email protected]
Anna Sönne, Head of Investor Relations and Sustainability +46 70 601 48 53 [email protected]
Humana AB Warfvinges väg 39, 7th fl. 112 51 Stockholm
Contact/information Telephone: +46 8-599 299 00 www.humanagroup.com